Page last updated: 2024-11-10

rhamnetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rhamnetin: aglycone of xanthorhamnin; from Rhamnus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

rhamnetin : A monomethoxyflavone that is quercetin methylated at position 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
RhamnusgenusA plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with HIPPOPHAE or KARWINSKIA. Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada. Members contain frangulanin, frangulin, and anthraquinones such as EMODIN.[MeSH]RhamnaceaeThe buckthorn plant family, of the order Rhamnales, includes some species with edible fruits and some that are medicinal.[MeSH]

Cross-References

ID SourceID
PubMed CID5281691
CHEMBL ID312163
CHEBI ID74992
SCHEMBL ID555118
MeSH IDM0175071

Synonyms (78)

Synonym
chebi:74992 ,
KBIO1_001503
DIVK1C_006559
NCI60_001648
SDCCGMLS-0066624.P001
SPECTRUM_001185
SPECTRUM4_001872
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4h-1-benzopyran-4-one
flavone, 3,3',4',5-tetrahydroxy-7-methoxy-
ccris 3792
brn 0047741
einecs 201-974-1
nsc 19802
3,3',4',5-tetrahydroxy-7-methoxyflavone
flavone, 7-methoxy-3,3',4',5-tetrahydroxy-
beta-rhamnocitrin
nsc19802 ,
7-o-methylquercetin
flavone,3',4',5-tetrahydroxy-7-methoxy-
4h-1-benzopyran-4-one,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-
7-methylquercetin
.beta.-rhamnocitrin
3,4',5-tetrahydroxy-7-methoxyflavone
7-methoxyquercetin
nsc-19802
c.i. 75690
NCGC00178254-01
SPECTRUM5_000464
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-chromen-4-one
90-19-7
rhamnetin
quercetin 7-methyl ether
NCGC00095624-01
NCGC00095624-02
KBIO2_004233
KBIOSS_001665
KBIOGR_002367
KBIO2_001665
KBIO2_006801
KBIO3_002345
SPECTRUM3_001343
SPECTRUM2_000642
SPBIO_000643
SPECPLUS_000463
SPECTRUM310031
BSPBIO_003125
bdbm23410
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4h-chromen-4-one
chembl312163 ,
LMPK12112624
3,5,3',4'-tetrahydroxy-7-methoxyflavone
NCGC00095624-03
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one
CCG-38555
FT-0672192
unii-71803l5f4s
3,5,3',4'-tetrahydroxy-7-methoxyflaone
71803l5f4s ,
5-18-05-00495 (beilstein handbook reference)
BRD-K37206356-001-01-3
SCHEMBL555118
rhamnetin [mi]
W-100338
JGUZGNYPMHHYRK-UHFFFAOYSA-N
mfcd00016931
DTXSID40237979
AKOS027320587
rhamnetin, analytical standard
SR-05000002269-2
sr-05000002269
J8G ,
Q288988
HY-N7036
CS-W014522
rhamnetin - tech grade ca 50%
AS-78315
E87178

Research Excerpts

Overview

Rhamnetin is a flavonoid that has antioxidant, anti-inflammatory and anti-cancer effects. It acts as a promising sensitizer to chemotherapy and may be a novel approach to overcome the MDR process.

ExcerptReferenceRelevance
"Rhamnetin is a naturally occurring polyphenolic compound. "( Rhamnetin attenuates melanogenesis by suppressing oxidative stress and pro-inflammatory mediators.
Kim, YJ, 2013
)
3.28
"Rhamnetin is a flavonoid that exhibits antioxidant capabilities."( Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under H₂O₂-induced apoptosis.
Jang, SY; Jang, YC; Kang, JC; Kim, B; Kim, DE; Park, ES; Park, JS; Shin, HS, 2014
)
1.42
"Rhamnetin acts as a promising sensitizer to chemotherapy and may be a novel approach to overcome the MDR process of HCC."( Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Cao, Y; Feng, F; Hou, MX; Jia, H; Jiang, QY; Ma, HD; Sun, HW; Wang, T; Yang, Q; Yang, YP, 2016
)
3.32
"Rhamnetin is a flavonoid that has antioxidant, anti-inflammatory and anti-cancer effects. "( May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?
Bircan, D; Bozkurt, O; Eroz, R; Ertekin, T; Nisari, M; Unur, E, 2016
)
2.08
"Rhamnetin appeared to be a much weaker mutagen in the Ames test."( Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.
Czeczot, H; Dobrowolska, B; Glinkowska, G; Kusztelak, J; Malinowski, J; Strzelecka, H; Szymczyk, T; Tudek, B, 1990
)
1

Effects

ExcerptReferenceRelevance
"Rhamnetin has an important role in preventing cancer formation. "( May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?
Bircan, D; Bozkurt, O; Eroz, R; Ertekin, T; Nisari, M; Unur, E, 2016
)
2.08
"Rhamnetin has an important role in preventing cancer formation. "( May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?
Bircan, D; Bozkurt, O; Eroz, R; Ertekin, T; Nisari, M; Unur, E, 2016
)
2.08

Treatment

Rhamnetin treatment decreased expression of the drug resistance-related downstream genes of PXR (cyp3a4 [cytochrome P-450] or mdr-1 [multi-drug resistance 1]), which mediate the metabolism or elimination of sorafenib in HCC cells. Treatment with rhamnetIn or cirsiliol reduced the proliferation of NSCLC cells through the suppression of radiation-induced Notch-1 expression.

ExcerptReferenceRelevance
"Rhamnetin treatment decreased expression of the drug resistance-related downstream genes of PXR (cyp3a4 [cytochrome P-450] or mdr-1 [multi-drug resistance 1]), which mediate the metabolism or elimination of sorafenib in HCC cells."( Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis.
Cao, S; Feng, F; Jia, H; Jiang, Q; Li, B; Lu, J; Wei, L; Zhang, Y, 2021
)
2.79
"The rhamnetin treatment group showed reductions in the lipid profile and levels of parameters of liver function compared to ApoE-/- mice."( Rhamnetin ameliorates macrophage-mediated inflammation and pro-atherosclerosis pathways in apolipoprotein E-deficient mice.
Li, W; Wang, M; Wu, Y, 2021
)
2.54
"Treatment with rhamnetin ameliorated the expression of TLR-4 mRNA and components of the TLR-4 pathway in the aortic tissue of ApoE-/- mice."( Rhamnetin ameliorates macrophage-mediated inflammation and pro-atherosclerosis pathways in apolipoprotein E-deficient mice.
Li, W; Wang, M; Wu, Y, 2021
)
2.4
"Treatment with rhamnetin or cirsiliol reduced the proliferation of NSCLC cells through the suppression of radiation-induced Notch-1 expression."( Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
Kang, J; Kim, E; Kim, J; Kim, JW; Kim, W; Seong, KM; Youn, B; Youn, H, 2013
)
2.17
"Treatment of rhamnetin also reduced the expression of MDR related proteins P-GP (P-glycoprotein) and BCRP (breast cancer resistance protein)."( Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Cao, Y; Feng, F; Hou, MX; Jia, H; Jiang, QY; Ma, HD; Sun, HW; Wang, T; Yang, Q; Yang, YP, 2016
)
2.23

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monomethoxyflavoneAny methoxyflavone with a single methoxy substituent.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
polymethylated quercetin biosynthesis210
eupatolitin 3-O-glucoside biosynthesis030
polymethylated quercetin biosynthesis211
eupatolitin 3-O-glucoside biosynthesis031

Protein Targets (37)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency3.98110.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency31.62280.004023.8416100.0000AID485290
Chain A, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency19.95260.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency22.38720.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency1.99530.125919.1169125.8920AID2549
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
Microtubule-associated protein tauHomo sapiens (human)Potency5.01190.180013.557439.8107AID1460
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency64.77570.010039.53711,122.0200AID1479
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency12.31290.00798.23321,122.0200AID2546; AID2551
DNA polymerase kappa isoform 1Homo sapiens (human)Potency2.46390.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency39.81070.031610.279239.8107AID884; AID885
lamin isoform A-delta10Homo sapiens (human)Potency11.22020.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency12.58930.316212.765731.6228AID881
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency12.58930.00638.235039.8107AID881
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency39.81071.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pancreatic alpha-amylaseSus scrofa (pig)IC50 (µMol)73.90001.35304.31088.9300AID1327604
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)2.70000.00101.191310.0000AID639825
ELAV-like protein 3Homo sapiens (human)IC50 (µMol)1.20000.20000.96001.8000AID1450465
Integrase Human immunodeficiency virus 1IC50 (µMol)45.15000.00051.544310.0000AID93507; AID93508
Inositol polyphosphate multikinaseHomo sapiens (human)IC50 (µMol)14.00001.10003.78337.2000AID1572025
Inositol hexakisphosphate kinase 2Homo sapiens (human)IC50 (µMol)1.80000.50002.35567.1000AID1572024
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (49)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
nervous system developmentELAV-like protein 3Homo sapiens (human)
cell differentiationELAV-like protein 3Homo sapiens (human)
inositol trisphosphate metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
inositol phosphate metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
phosphatidylinositol metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
necroptotic processInositol polyphosphate multikinaseHomo sapiens (human)
inositol phosphate biosynthetic processInositol polyphosphate multikinaseHomo sapiens (human)
negative regulation of cell growthInositol hexakisphosphate kinase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationInositol hexakisphosphate kinase 2Homo sapiens (human)
positive regulation of apoptotic processInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 2Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 2Homo sapiens (human)
protein stabilizationInositol hexakisphosphate kinase 2Homo sapiens (human)
cellular response to flavonoidInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (35)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingELAV-like protein 3Homo sapiens (human)
mRNA 3'-UTR AU-rich region bindingELAV-like protein 3Homo sapiens (human)
inositol-1,4,5-trisphosphate 6-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 6-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
protein bindingInositol polyphosphate multikinaseHomo sapiens (human)
ATP bindingInositol polyphosphate multikinaseHomo sapiens (human)
inositol-1,4,5-trisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
metal ion bindingInositol polyphosphate multikinaseHomo sapiens (human)
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 5-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
flavonoid bindingInositol polyphosphate multikinaseHomo sapiens (human)
myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
flavonoid bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
ribonucleoprotein complexELAV-like protein 3Homo sapiens (human)
nucleoplasmInositol polyphosphate multikinaseHomo sapiens (human)
nucleusInositol polyphosphate multikinaseHomo sapiens (human)
cytoplasmInositol polyphosphate multikinaseHomo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 2Homo sapiens (human)
cell junctionInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 2Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (110)

Assay IDTitleYearJournalArticle
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1327604Inhibition of hog pancreas alpha-amylase using starch as substrate preincubated for 10 mins followed by substrate addition measured after 10 mins by dinitrosalicylic acid color reagent-based UV-Vis spectrophotometric analysis2016Journal of natural products, 08-26, Volume: 79, Issue:8
α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium.
AID1066474Binding affinity to human C-terminal His6-tagged JNK1alpha1 (1 to 364) expressed in Escherichia coli by circular dichroism method2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID603836Effect on ERK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID603844Stability of the compound in DMEM media assessed as compound degradation at 25 ppm after 3 hrs by HPLC2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID666770Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1572042Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1153996Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID93508IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration1995Journal of medicinal chemistry, Mar-17, Volume: 38, Issue:6
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
AID1066486Inhibition of LPS-induced JNK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID666771Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID596671Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1066482Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of IFNgamma-induced NO production at 10 uM after 24 hrs2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066498Cytotoxicity against mouse RAW264.7 cells up to 12.5 uM after 24 hrs by MTT assay relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066476Binding affinity to human C-terminal His6-tagged JNK1alpha1 (1 to 364) expressed in Escherichia coli by spectrofluorometry2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1154003Cytotoxicity against mouse B16F0 cells assessed as cell viability at 25 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID666768Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID603835Effect on JNK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1066495Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced NO production at 10 uM after 24 hrs2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID334648Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs
AID603837Effect on ERK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID144650In vitro cytotoxic potency against NCI-60 human tumor cell line1998Journal of medicinal chemistry, Jun-18, Volume: 41, Issue:13
Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
AID334647Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs
AID353598Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1066493Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 10 uM after 24 hrs by ELISA2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066480Inhibition of IFNgamma-induced p38 MAPK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066477Inhibition of CD14 in mouse RAW264.7 cells at 20 uM by Western blotting analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1153995Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1066485Inhibition of LPS-induced p38 MAPK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID334641Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID355888Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID334642Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1871811Anticoagulant activity in rabbit plasma assessed as thrombin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID355885Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID426927Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay2009Journal of natural products, Jun, Volume: 72, Issue:6
7-O-methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii.
AID1871812Anticoagulant activity in rabbit plasma assessed as activated partial thromboplastin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID654747Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli at 20 nM to 20 uM after 1 hr incubation followed by overnight incubation by Alpha screening technique2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
AID1066475Binding affinity to human p38 MAPK expressed in Escherichia coli by spectrofluorometry2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID334638Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID355887Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID1572024Inhibition of human IP6K2 using insP6 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1572026Selectivity ratio of IC50 for human IPMK to IC50 for human IP6K22019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1066497Cytotoxicity against mouse RAW264.7 cells assessed as cell survival at 100 uM after 24 hrs by MTT assay relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID603838Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID596670Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID353599Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID596672Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1066490Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 level at 20 uM after 24 hrs by ELISA relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066481Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of IFNgamma-induced NO production at 20 uM after 24 hrs2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID603839Increase in JNK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID603843Induction of apoptosis in human MDA-MB-231 cells assessed as cleaved caspase-7 accumulation at 20 uM after 12 hrs by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1154004Cytotoxicity against mouse B16F0 cells assessed as cell viability at 12.5 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID353590Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID404067In vivo antitumor activity against mouse S180 cells
AID1066483Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced COX2 protein expression at 20 uM by Western blotting analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID404692Inhibition of human salivary alpha-amylase2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
AID379055Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID1154001Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID603841Increase in JNK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1066479Inhibition of IFNgamma-induced ERK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1871813Anticoagulant activity in rabbit plasma assessed as prothrombin time2022European journal of medicinal chemistry, Jan-15, Volume: 228Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
AID404069In vivo antitumor activity against mouse L1210 cells
AID1572025Inhibition of human IPMK using insP3 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1066491Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 level at 10 uM after 24 hrs by ELISA relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1066492Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 20 uM after 24 hrs by ELISA2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID596673Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID423636Cytotoxicity against human HeLa cells by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Cytotoxic constituents of chinese propolis.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1572043Down regulation of insp5 levels in human [3H]-inositol-labelled HCT116 cells at 2.5 uM after 3.5 hrs by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1154000Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1450465Inhibition of ELAV3 (unknown origin)-artificial ARE complex formation after 30 mins in the presence of biotin-labeled RNA probe by chemiluminescence nucleic acid detection method2017Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20
Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.
AID666769Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1066496Cytotoxicity against human HaCaT cells at 100 uM after 24 hrs by MTT assay relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID603834Effect on JNK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID334639Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID596669Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 0.3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID404070In vivo antitumor activity against mouse CA-755 cells
AID353591Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID93507IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage1995Journal of medicinal chemistry, Mar-17, Volume: 38, Issue:6
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
AID1154005Cytotoxicity against mouse B16F0 cells assessed as cell viability at 6.25 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID603840Increase in ERK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1153999Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID334644Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID603842Increase in ERK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1572044Inhibition of IPMK in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp5 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1066489Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-2 mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID1066488Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mTNFalpha mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID639825Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Feb-01, Volume: 20, Issue:3
Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
AID603831Increase in c-Fos protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1066478Inhibition of IFNgamma-induced JNK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID603832Increase in Egr-1 protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1066484Inhibition of LPS-induced ERK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID310882Inhibition of HIV1 replication2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
AID1066487Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced mMIP-1 mRNA expression at 25 uM after 3 hrs by RT-PCR analysis relative to untreated control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID426928Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as total inhibitory concentration after 3 days by plaque reduction assay2009Journal of natural products, Jun, Volume: 72, Issue:6
7-O-methylkaempferol and -quercetin glycosides from the whole plant of Nervilia fordii.
AID1066473Binding affinity to human p38 MAPK expressed in Escherichia coli by circular dichroism method2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID603833Effect on p38 kinase protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID334645Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1066494Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced NO production at 20 uM after 24 hrs2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK.
AID1153997Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (77)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.30)18.7374
1990's11 (14.29)18.2507
2000's13 (16.88)29.6817
2010's39 (50.65)24.3611
2020's13 (16.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.33 (24.57)
Research Supply Index4.39 (2.92)
Research Growth Index5.68 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other77 (96.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]